On catalepsy and catatonia and the predictability of the catalepsy test for neuroleptic activity.
D000679:Amygdala / Q000502:physiology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D002375:Catalepsy / Q000139:chemically induced*; D002389:Catatonia / Q000139:chemically induced*; D002421:Caudate Nucleus / Q000502:physiology; D003342:Corpus Striatum / Q000502:physiology; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D005917:Globus Pallidus / Q000502:physiology; D006220:Haloperidol / Q000494:pharmacology; D006801:Humans; D007031:Hypothalamus / Q000502:physiology; D008297:Male; D009020:Morphine / Q000494:pharmacology; D009269:Nalorphine / Q000494:pharmacology; D051381:Rats; D013238:Stereotaxic Techniques; D013997:Time Factors
D009020:Morphine; D001285:Atropine; D006220:Haloperidol; D009269:Nalorphine